R
Avidity Biosciences D
D
RNA
29.290
USD
-0.03
(-0.10%)
مغلق
حجم التداول
41,294
الربح لكل سهم
-3
العائد الربحي
-
P/E
-10
حجم السوق
3,530,029,863
الأخبار المقالات
العنوان: Avidity Biosciences
القطاع: Healthcare
الصناعة: Biotechnology
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.